Platelet RNA signatures for the detection of cancer

Nik Sol1,2, Thomas Wurdinger3,4,5

  • 1Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. ni.sol@vumc.nl.

Insights

Platelets contain RNA processing machinery and can acquire RNA from external sources. This review explores how cancer influences platelet RNA biomarker signatures.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Platelets possess RNA processing capabilities, including pre-mRNA splicing, pre-miRNA processing, and mRNA translation.
  • Most platelet RNA originates from megakaryocytes, but platelets can also internalize RNA from circulation or other cells.
  • While traditionally known for hemostasis and thrombosis, platelets' roles in other biological processes are increasingly recognized.

Purpose of the Study:

  • To review the alterations in platelet RNA biomarker signatures associated with cancer.
  • To highlight the expanding roles of platelets beyond hemostasis.

Main Methods:

  • Literature review of studies investigating platelet RNA.
  • Analysis of how cancer affects platelet RNA content and processing.

Main Results:

  • Platelet RNA signatures are dynamic and can be modified by the presence of cancer.
  • Platelets' involvement in biological processes extends beyond their established roles.

Conclusions:

  • Platelet RNA biomarkers show potential for cancer detection or monitoring.
  • Further research into platelet biology is warranted to understand their full range of functions, particularly in cancer.

Related Concept Videos